IsoPlexis is dedicated to the fight against cancer and a range of the world's toughest diseases with its uniquely correlative, award-winning single-cell detection systems. By revealing unique immune biomarkers in small subsets of cells, we advance immunotherapies and targeted therapies to a highly precise, personalized stage. Our integrated systems are used globally to advance the field of single-cell biology and biomarkers as we generate solutions to overcome the challenges of complex diseases.